Bob M. Moore II, Ph.D.

Bob M. Moore II, Ph.D.

Professor


Department of Pharmaceutical Sciences


The University of Tennessee Health Science Center
874 Union Avenue, Room 327D
Memphis, TN 38163
Tel: (901) 448-6085
Fax: (508) 448-6828
Email: Bob M. Moore



Education

  • B.S. in Chemistry, Indiana State University, 1983
  • M.S. in Chemistry, Indiana State University, 1989
  • Ph.D. (Medicinal Chemistry), University of Kansas, 1995

Research Interests

Research in Dr. Moore's lab integrates synthetic organic chemistry, computational chemistry and biological assays aimed at developing new chemotherapeutic entities. The current areas of research include:

  1. Development of cannabinoid receptor (CB1 and CB2) agonist and antagonist.
  2. Development of novel therapies for combat causality care with emphasis on hemorrhagic shock and hemostasis.
  3. Development of GPRC directed anti-neoplastic agents.
  4. Combination drug therapies for the treatment of sepsis, stroke and ischemic brain conditions.

Representative Publications

  • Wang P, Moore BM, Panchy NL, Meng F, Lehti-Shiu MD, Shiu SH. Factors influencing gene family size variation among related species in a plant family, Solanaceae. Genome Biol Evol. 2018 Sep 18. doi: 10.1093/gbe/evy193. [Epub ahead of print] PubMed PMID: 30239695.
  • Moore BM, Cordina RL, McGuire MA, Celermajer DS. Adverse effects of amiodarone therapy in adults with congenital heart disease. Congenit Heart Dis. 2018 Sep 21. doi: 10.1111/chd.12657. [Epub ahead of print] PubMed PMID: 30239160.
  • Moore BM, Schellinger K. An Examination of the Moderating Effect of Proactive Coping in NICU Nurses. J Perinat Neonatal Nurs. 2018 Jul/Sep;32(3):275-285. doi: 10.1097/JPN.0000000000000353. PubMed PMID: 30036310.
  • Moore BM, Adams JT, Willcox S, Nicholson J. The Effect of Active Physical Training Interventions on Reactive Postural Responses in Older Adults: A Systematic Review. J Aging Phys Act. 2018 Jul 10:1-42. doi: 10.1123/japa.2017-0347. [Epub ahead of print] PubMed PMID: 29989462.
  • Moore BM, Cordina RL, McGuire MA, Celermajer DS. Efficacy and adverse effects of sotalol in adults with congenital heart disease. Int J Cardiol. 2018 Jun 20. pii: S0167-5273(18)32425-2. doi: 10.1016/j.ijcard.2018.06.066. [Epub ahead of print] PubMed PMID: 29954667.
  • Yu C, Moore BM, Kotchetkova I, Cordina RL, Celermajer DS. Causes of death in a contemporary adult congenital heart disease cohort. Heart. 2018 Apr 17. pii: heartjnl-2017-312777. doi: 10.1136/heartjnl-2017-312777. [Epub ahead of print] PubMed PMID: 29666178.

View more references (pubmed link)